Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)

Leif Bjermer,1 Piotr Kuna,2 Carin Jorup,3 Thomas Bengtsson,4 Johan Rosenborg4 1Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden; 2Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; 3AstraZ...

Full description

Bibliographic Details
Main Authors: Bjermer L, Kuna P, Jorup C, Bengtsson T, Rosenborg J
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/clinical-pharmacokinetics-of-azd3199-an-inhaled-ultra-long-acting-beta-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/clinical-pharmacokinetics-of-azd3199-an-inhaled-ultra-long-acting-beta-peer-reviewed-article-DDDT

Similar Items